ClinicalTrials.Veeva

Menu

MRI Study - Chronic Progressive External Ophthalmoplegia (CPEO)

Rigshospitalet logo

Rigshospitalet

Status

Completed

Conditions

Chronic Progressive External Ophthalmoplegia

Treatments

Other: Magnetic Resonance Imaging

Study type

Observational

Funder types

Other

Identifiers

NCT02161848
H-3-2012-163 (CPEO)

Details and patient eligibility

About

The purpose of this study is to investigate the fraction of fat on a MRI scan of lower bag muscles, thighs and calves in patients with the mitochondrial disease chronic progressive external ophthalmoplegia (CPEO).

Additionally an investigation of the volume of the eye muscles will be done and compared to the patient's clinical presentation of ptosis and ophthalmoplegia.

Full description

The lack of energy and fatigue seen in patients with mitochondrial diseases have been assumed to be caused by an energy defect because of a genetic defect in the mitochondrial DNA.

The investigators have analyzed a few MRI scans of muscles from patients with CPEO and have seen an extended amount of fat in their muscles, which seems to progress with age. The patient's symptoms might be caused by the extended amount of fat and thereby a less amount of active muscle instead of the "energy defect".

This will be investigated in a group of patients with CPEO and the results will be compared with results from a group of healthy controls.

Enrollment

133 patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Danish patients with verified single large-scale mtDNA deletions and chronic progressive external ophthalmoplegia.

Exclusion criteria

  • Patients who have metal implants in the body, for instance surgical clips, cochlear implant, pacemaker etc.
  • Patients who are pregnant or breast-feeding.
  • Patients who are claustrophobic

Trial design

133 participants in 3 patient groups

Patients
Description:
Patients with verified singe large-scale mtDNA deletions and chronic progressive external ophthalmoplegia.
Treatment:
Other: Magnetic Resonance Imaging
Controls
Description:
Healthy controls matched for age and gender.
Treatment:
Other: Magnetic Resonance Imaging
Patient group as Controls
Description:
Patients with mitochondrial DNA 3243A\>G mutations
Treatment:
Other: Magnetic Resonance Imaging

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems